Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy.
Stüve O, Cravens PD, Frohman EM, Phillips JT, Remington GM, von Geldern G, Cepok S, Singh MP, Tervaert JW, De Baets M, MacManus D, Miller DH, Radü EW, Cameron EM, Monson NL, Zhang S, Kim R, Hemmer B, Racke MK.
Stüve O, et al. Among authors: cameron em.
Neurology. 2009 Feb 3;72(5):396-401. doi: 10.1212/01.wnl.0000327341.89587.76. Epub 2008 Nov 5.
Neurology. 2009.
PMID: 18987352
Free PMC article.
Clinical Trial.